Market News AIOpen the app

Dr. Reddy's got the green light from CDSCO to use Zytorvi for treating esophageal cancer.

TrialRead the original at marketscreener.com
Good for RDY

Dr. Reddy's won Indian approval for Zytorvi to treat esophageal cancer.

RDY · Dr. Reddy's Laboratories

AI read · Good for RDY

The AI's read

The approval gives Zytorvi a new use in India. It may help Dr. Reddy's reach more patients and add sales, but the report gives no sales or patient-use figures.

Get alerts for RDY

Follow Dr. Reddy's Laboratories (RDY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RDY
Free on the App Store and Google Play, or on the web.